• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Hypertension costs $131 billion


CDC recommends value-based strategies to help members control high blood pressure

A new report on hypertension released by the Centers for Disease Control and Prevention recommends a value based approach to care, including 90 day prescription fills and low or zero copays for medication.

According to CDC, most people who know they have hypertension fail to control it. Up to 16 million people report being on medication and seeing a provider at least twice a year. Costs associated with the condition reach nearly $131 billion per year and it accounts for nearly 1,000 deaths per day.

For Medicare Advantage plans, CMS measures the percentage of members age 18 to 85 years old who have control of blood pressure in the star rating program. The four-star threshold is 63 percent.

Related Content
© 2023 MJH Life Sciences

All rights reserved.